The dominant market consensus around an 85–90 cumulative flu hospitalization rate for Week 19, 2026, reflects CDC FluSurv-NET data showing the rate climbing steadily through spring before plateauing near 85 per 100,000 population by mid-May. This positioning stems from the sharp seasonal decline in influenza transmission as warmer temperatures reduce viral stability and community mixing, with weekly rates dropping to minimal levels after the winter peak driven largely by influenza A(H3N2). Historical patterns confirm that late-season additions rarely exceed a few points once activity falls below epidemic thresholds. Only an unforeseen late surge or major reporting revisions could shift the final figure outside this band, though current surveillance trends make such outcomes improbable before the CDC’s official release.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoFlu Hospitalization Rate Week 19, 2026?
Flu Hospitalization Rate Week 19, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$18,757 Vol.
$18,757 Vol.
22 mag 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$18,757 Vol.
$18,757 Vol.
22 mag 2026
<80
$1,614 Vol.
No
80–85
$4,802 Vol.
No
85–90
$6,820 Vol.
Yes
90–95
$3,313 Vol.
No
95–100
$1,533 Vol.
No
100+
$674 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative flu hospitalization rate for Week 19, 2026, reflects CDC FluSurv-NET data showing the rate climbing steadily through spring before plateauing near 85 per 100,000 population by mid-May. This positioning stems from the sharp seasonal decline in influenza transmission as warmer temperatures reduce viral stability and community mixing, with weekly rates dropping to minimal levels after the winter peak driven largely by influenza A(H3N2). Historical patterns confirm that late-season additions rarely exceed a few points once activity falls below epidemic thresholds. Only an unforeseen late surge or major reporting revisions could shift the final figure outside this band, though current surveillance trends make such outcomes improbable before the CDC’s official release.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Mercato aperto: May 14, 2026, 7:51 PM ET
Volume
$18,757Data di fine
22 mag 2026Mercato aperto
May 14, 2026, 7:51 PM ETResolver
0x69c47De9D...Esito proposto: No
Nessuna contestazione
Esito finale: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative flu hospitalization rate for Week 19, 2026, reflects CDC FluSurv-NET data showing the rate climbing steadily through spring before plateauing near 85 per 100,000 population by mid-May. This positioning stems from the sharp seasonal decline in influenza transmission as warmer temperatures reduce viral stability and community mixing, with weekly rates dropping to minimal levels after the winter peak driven largely by influenza A(H3N2). Historical patterns confirm that late-season additions rarely exceed a few points once activity falls below epidemic thresholds. Only an unforeseen late surge or major reporting revisions could shift the final figure outside this band, though current surveillance trends make such outcomes improbable before the CDC’s official release.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$18,757Data di fine
22 mag 2026Mercato aperto
May 14, 2026, 7:51 PM ETResolver
0x69c47De9D...Esito proposto: No
Nessuna contestazione
Esito finale: No
The dominant market consensus around an 85–90 cumulative flu hospitalization rate for Week 19, 2026, reflects CDC FluSurv-NET data showing the rate climbing steadily through spring before plateauing near 85 per 100,000 population by mid-May. This positioning stems from the sharp seasonal decline in influenza transmission as warmer temperatures reduce viral stability and community mixing, with weekly rates dropping to minimal levels after the winter peak driven largely by influenza A(H3N2). Historical patterns confirm that late-season additions rarely exceed a few points once activity falls below epidemic thresholds. Only an unforeseen late surge or major reporting revisions could shift the final figure outside this band, though current surveillance trends make such outcomes improbable before the CDC’s official release.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti